FDA Warning Letter Response

FDA WARNING LETTER RESPONSE

Evidence, Corrective-Action, and Submission Worksheet

Build the response from the actual warning letter and current official sources. Do not reuse a deadline, mailing address, submission method, statutory citation, or commitment from another matter.

1. Matter-Control Sheet

Calendar the exact instruction in the warning letter. If a date, extension, recipient, or transmission method is uncertain, obtain direction from the named FDA contact and preserve the communication.

2. Current-Authority Gate

For every citation or legal conclusion, open the current official text during response preparation.

The warning letter may quote, paraphrase, incorporate, or link other material. Record the exact authority actually relied on; a generic enforcement manual or regulation part does not substitute for the specific cited requirement.

3. Preservation, Safety, and Escalation

☐ Preserve the warning letter, envelope/transmission record, inspection records, correspondence, drafts, data, samples, photographs, labels, websites, complaints, adverse-event information, distribution records, and relevant electronic metadata under the organization's approved process.

☐ Escalate any ongoing product, patient, consumer, clinical, data-integrity, sterility, contamination, labeling, cybersecurity, reporting, or distribution risk to authorized subject-matter personnel.

☐ Identify any recall, correction, market action, field communication, reporting, import, application, consent-decree, injunction, investigation, criminal, civil, or parallel-agency issue requiring separate advice.

☐ Separate factual investigation from privileged legal advice and label materials only under the organization's approved privilege and confidentiality protocol.

4. Observation-by-Observation Response Matrix

Create one row for every observation, example, product, lot, facility, webpage, document, and cited requirement.

“Dispute” and “clarify” entries must identify the precise factual or legal basis and supporting record. Do not obscure a confirmed issue with general assurances.

5. Factual Investigation Record

Distinguish verified facts, reasonable inferences, expert conclusions, and items still under investigation.

6. Correction and CAPA Plan

6.1 Immediate Correction or Containment

6.2 Root-Cause Analysis

6.3 Corrective and Preventive Action

A planned action is not a completed action. State status, dependencies, assumptions, and evidence accurately.

7. Scope and Systemic Review

Explain why the review scope and method are appropriate to the specific observation.

8. Product and Public-Health Assessment

Use qualified scientific, medical, quality, engineering, statistical, and regulatory reviewers as the subject requires.

Do not state that a risk or affected population is absent unless the supporting assessment is complete and documented.

9. Commitment Register

Commit only to actions the authorized organization can perform and support.

For incomplete work, explain what remains, why the proposed date is supportable, what interim control applies, and when evidence will be provided. Do not silently change a submitted commitment.

10. Draft Response Structure

10.1 Opening

• Identify the company, facility, letter, and authorized signer.
• State the response date and contact person.
• Describe the attachment and cross-reference convention.
• Use reviewed language for any acknowledgement, disagreement, or reservation.

10.2 Each Observation

For Observation [ID]:

1. Quote or identify the observation and cited authority accurately.
2. State the response position.
3. Provide the verified facts and investigation scope.
4. Describe completed correction and attach evidence.
5. Explain root cause and systemic scope review.
6. Describe open actions, owners, dates, interim controls, and effectiveness checks.
7. Cross-reference attachments by final number and page.

10.3 Closing

• Summarize open commitments without overstating completion.
• Provide the authorized contact.
• Request or propose follow-up only as approved.
• Use only an authorized signature and certification.

11. Attachment and Confidentiality Review

Confirm that every referenced attachment exists, is legible, matches the cited version, and contains no draft comment, hidden sheet, broken link, unsupported conclusion, unnecessary personal data, or privileged communication.

Record the current official procedure for any confidentiality request, redaction, protected submission, or public-disclosure issue: [SOURCE / URL / PROCEDURE].

12. Accuracy and Authorization Review

Do not use a blanket “accurate and complete” certification unless its exact wording and signer are authorized for this response.

13. Submission and Receipt Log

14. Post-Submission Tracker

Preserve the final signed response, attachments, proof of submission, FDA communications, commitment updates, and completion/effectiveness evidence under the approved records process.

15. Official Sources Used for This Matter

Only list sources actually opened and used for this response.